Arlo Technologies Completes Acquisition of Aloe Care Health
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 16 2026
0mins
Should l Buy ARLO?
Arlo Technologies announced that it has completed the acquisition of Aloe Care Health, an AI-powered medical alert and fall prevention platform that delivers improved outcomes for patients and their caregivers. "Today's announcement highlights Arlo's entry into an enormous, underserved market that demands innovation and new services to enable an appropriate level of care at home," said Matthew McRae, CEO of Arlo Technologies. "We are excited to combine Aloe Care's class-leading solutions with Arlo's scaled, AI-driven, and privacy-first SaaS platform to maximize the impact in this critical market."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ARLO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ARLO
Wall Street analysts forecast ARLO stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 14.750
Low
26.00
Averages
26.00
High
26.00
Current: 14.750
Low
26.00
Averages
26.00
High
26.00
About ARLO
Arlo Technologies, Inc. is a smart home security platform company. The Company offers advanced home, business, and personal security services that combine a globally scaled cloud platform, advanced monitoring and analytics capabilities, and app-controlled devices to create a personalized security ecosystem. Its expertise in cloud services, artificial intelligence (AI) and computer vision analytics, wireless connectivity and intuitive user experience design deliver seamless, smart home security for its users. Its cloud-based platform provides users with visibility, insight and a powerful means to help protect and connect in real-time with the people and things that matter, from any location with a Wi-Fi or a cellular connection. Its products include Arlo Essential Cameras and Doorbells; Arlo Home Security System; Arlo Pro 5S; Arlo Go 2; Arlo Ultra 2; Arlo Floodlight Camera, and others. Its services include Arlo Secure, Arlo Total Security, Arlo Safe, and other services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Arlo Grants Equity Awards to New Employees Under 2018 Plan
- Equity Award Program: On May 5, 2026, Arlo Technologies granted 556,850 shares of restricted stock units (RSUs) and performance-vesting stock units (PSUs) to 25 new employees under its 2018 Equity Incentive Plan, highlighting the company's commitment to attracting talent.
- RSU and PSU Structure: Of the total, 464,638 shares are RSUs that vest in four equal annual installments, while 92,212 shares are PSUs that vest based on the company's achievement of financial targets related to annual recurring revenue and gross margin, reflecting a performance-driven incentive approach.
- Performance-Driven Incentives: The actual number of shares issuable under the PSUs will vary between 0-200% based on the company's performance relative to the targets, designed to motivate employees to contribute to the company's long-term success and enhance team cohesion.
- Continuous Service Requirement: All RSUs and PSUs are contingent upon each employee's continued service at the vesting date, ensuring the company retains key talent and promotes stable business growth.
See More
Arlo Grants Equity Awards to New Employees Under 2018 Plan
- Equity Award Program: On May 5, 2026, Arlo Technologies granted 556,850 shares of restricted stock units (RSUs) and performance-vesting stock units (PSUs) to 25 new employees under its 2018 Equity Incentive Plan, emphasizing the company's commitment to attracting talent.
- RSUs and PSUs Structure: Of the total, 464,638 shares of RSUs will vest in four equal annual installments, while 92,212 shares of PSUs will vest based on the company's achievement of financial targets related to annual recurring revenue and gross margin, highlighting a strong focus on performance.
- Performance-Driven Incentives: The actual number of shares for PSUs will vary between 0-200% based on company performance, which not only motivates employees to achieve corporate goals but also strengthens their commitment to the company's long-term growth.
- Continued Service Requirement: All granted RSUs and PSUs are contingent upon each employee's continued service with the company at the vesting date, ensuring alignment of employee interests with the company's long-term objectives and enhancing team stability and cohesion.
See More
Arlo Technologies Acquires Aloe Care Health to Enhance SaaS Offerings
- Acquisition Completed: Arlo Technologies has finalized its acquisition of Aloe Care Health, further expanding its software-as-a-service platform into aging-in-place and wellness care services, targeting the needs of the growing population aged 65 and older.
- Technology Enhancement: This transaction adds AI-powered medical alert and fall prevention capabilities to Arlo's product portfolio, not only enhancing its competitive edge in smart home services but also strengthening its position in the healthcare solutions market.
- Market Expansion Strategy: Arlo stated that the acquisition supports its strategy to expand into new markets with a focus on healthcare and caregiving solutions, which is expected to drive future business growth.
- Financial Outlook: Although the financial terms of the deal were not disclosed, Arlo projects service revenue to reach $375 million to $385 million by 2026, indicating a positive outlook driven by partnerships and its SaaS model.
See More
Arlo Technologies General Counsel Sells $352K in Shares
- Sale Context: Brian Busse, General Counsel of Arlo Technologies, sold 25,525 shares for approximately $352K on March 12, 2026, primarily to cover tax withholding obligations related to 50,000 shares from a performance stock unit (PSU) plan.
- Ownership Reduction: This transaction reduced Busse's direct holdings by 4.19%, leaving him with 583,364 shares valued at about $7.88 million, underscoring his significant stake in the company.
- Financial Performance: Arlo Technologies reported its first net income in fiscal year 2025, with total revenue reaching $529.3 million and net income of $14.93 million, indicating strong growth potential in the smart home security sector.
- Stock Buyback Program: The company's board approved a $50 million stock repurchase program set to continue through December 31, 2027, which may further drive share prices up and enhance investor confidence.
See More
Rice Hall James Increases Stake in QuidelOrtho
- Share Increase: Rice Hall James & Associates acquired 574,877 shares of QuidelOrtho in Q4 2026, reflecting confidence in the company's future prospects despite a 43.4% decline in stock price over the past year.
- Investment Value: This acquisition raised QuidelOrtho's stake to 1.3% of the fund's 13F reportable assets, indicating recognition of its potential value, which may attract further investor interest.
- Market Performance: As of February 13, 2026, QuidelOrtho's market capitalization stood at $1.6 billion with a current price of $23.58, trailing the S&P 500 by 55.2 percentage points, highlighting competitive pressures in the market.
- Strategic Adjustments: QuidelOrtho is undergoing strategic adjustments, including strengthening its product pipeline and improving spending returns, with analysts expecting these efforts to yield modest revenue and operating profit growth in the coming years.
See More
Rice Hall James Increases Stake in QuidelOrtho
- Increased Holdings: Rice Hall James purchased 574,877 shares of QuidelOrtho in Q4, raising its total stake to 833,791 shares valued at $23.8 million, reflecting a positive outlook on the company's future prospects.
- Investment Value Growth: The position's value increased by $16.2 million at quarter-end, indicating a rise in stock price and additional share purchases, suggesting the fund's optimistic view on QuidelOrtho's potential value.
- Industry Position: As a leader in in vitro diagnostics, QuidelOrtho has struggled with consistent revenue growth and profitability in recent years, but its strategic adjustments and strengthened product pipeline may improve financial performance, attracting value investors.
- Market Expectations: Analysts expect QuidelOrtho to achieve modest revenue and operating profit growth in the coming years, although the Motley Fool analyst team did not include it in their list of top investment stocks, indicating a divergence in market perceptions of its potential.
See More
Arlo Grants Equity Awards to New Employees Under 2018 Plan
- Equity Award Program: On May 5, 2026, Arlo Technologies granted 556,850 shares of restricted stock units (RSUs) and performance-vesting stock units (PSUs) to 25 new employees under its 2018 Equity Incentive Plan, highlighting the company's commitment to attracting talent.
- RSU and PSU Structure: Of the total, 464,638 shares are RSUs that vest in four equal annual installments, while 92,212 shares are PSUs that vest based on the company's achievement of financial targets related to annual recurring revenue and gross margin, reflecting a performance-driven incentive approach.
- Performance-Driven Incentives: The actual number of shares issuable under the PSUs will vary between 0-200% based on the company's performance relative to the targets, designed to motivate employees to contribute to the company's long-term success and enhance team cohesion.
- Continuous Service Requirement: All RSUs and PSUs are contingent upon each employee's continued service at the vesting date, ensuring the company retains key talent and promotes stable business growth.
See More
Arlo Grants Equity Awards to New Employees Under 2018 Plan
- Equity Award Program: On May 5, 2026, Arlo Technologies granted 556,850 shares of restricted stock units (RSUs) and performance-vesting stock units (PSUs) to 25 new employees under its 2018 Equity Incentive Plan, emphasizing the company's commitment to attracting talent.
- RSUs and PSUs Structure: Of the total, 464,638 shares of RSUs will vest in four equal annual installments, while 92,212 shares of PSUs will vest based on the company's achievement of financial targets related to annual recurring revenue and gross margin, highlighting a strong focus on performance.
- Performance-Driven Incentives: The actual number of shares for PSUs will vary between 0-200% based on company performance, which not only motivates employees to achieve corporate goals but also strengthens their commitment to the company's long-term growth.
- Continued Service Requirement: All granted RSUs and PSUs are contingent upon each employee's continued service with the company at the vesting date, ensuring alignment of employee interests with the company's long-term objectives and enhancing team stability and cohesion.
See More
Arlo Technologies Acquires Aloe Care Health to Enhance SaaS Offerings
- Acquisition Completed: Arlo Technologies has finalized its acquisition of Aloe Care Health, further expanding its software-as-a-service platform into aging-in-place and wellness care services, targeting the needs of the growing population aged 65 and older.
- Technology Enhancement: This transaction adds AI-powered medical alert and fall prevention capabilities to Arlo's product portfolio, not only enhancing its competitive edge in smart home services but also strengthening its position in the healthcare solutions market.
- Market Expansion Strategy: Arlo stated that the acquisition supports its strategy to expand into new markets with a focus on healthcare and caregiving solutions, which is expected to drive future business growth.
- Financial Outlook: Although the financial terms of the deal were not disclosed, Arlo projects service revenue to reach $375 million to $385 million by 2026, indicating a positive outlook driven by partnerships and its SaaS model.
See More
Arlo Technologies General Counsel Sells $352K in Shares
- Sale Context: Brian Busse, General Counsel of Arlo Technologies, sold 25,525 shares for approximately $352K on March 12, 2026, primarily to cover tax withholding obligations related to 50,000 shares from a performance stock unit (PSU) plan.
- Ownership Reduction: This transaction reduced Busse's direct holdings by 4.19%, leaving him with 583,364 shares valued at about $7.88 million, underscoring his significant stake in the company.
- Financial Performance: Arlo Technologies reported its first net income in fiscal year 2025, with total revenue reaching $529.3 million and net income of $14.93 million, indicating strong growth potential in the smart home security sector.
- Stock Buyback Program: The company's board approved a $50 million stock repurchase program set to continue through December 31, 2027, which may further drive share prices up and enhance investor confidence.
See More
Rice Hall James Increases Stake in QuidelOrtho
- Share Increase: Rice Hall James & Associates acquired 574,877 shares of QuidelOrtho in Q4 2026, reflecting confidence in the company's future prospects despite a 43.4% decline in stock price over the past year.
- Investment Value: This acquisition raised QuidelOrtho's stake to 1.3% of the fund's 13F reportable assets, indicating recognition of its potential value, which may attract further investor interest.
- Market Performance: As of February 13, 2026, QuidelOrtho's market capitalization stood at $1.6 billion with a current price of $23.58, trailing the S&P 500 by 55.2 percentage points, highlighting competitive pressures in the market.
- Strategic Adjustments: QuidelOrtho is undergoing strategic adjustments, including strengthening its product pipeline and improving spending returns, with analysts expecting these efforts to yield modest revenue and operating profit growth in the coming years.
See More
Rice Hall James Increases Stake in QuidelOrtho
- Increased Holdings: Rice Hall James purchased 574,877 shares of QuidelOrtho in Q4, raising its total stake to 833,791 shares valued at $23.8 million, reflecting a positive outlook on the company's future prospects.
- Investment Value Growth: The position's value increased by $16.2 million at quarter-end, indicating a rise in stock price and additional share purchases, suggesting the fund's optimistic view on QuidelOrtho's potential value.
- Industry Position: As a leader in in vitro diagnostics, QuidelOrtho has struggled with consistent revenue growth and profitability in recent years, but its strategic adjustments and strengthened product pipeline may improve financial performance, attracting value investors.
- Market Expectations: Analysts expect QuidelOrtho to achieve modest revenue and operating profit growth in the coming years, although the Motley Fool analyst team did not include it in their list of top investment stocks, indicating a divergence in market perceptions of its potential.
See More
